EXTON, Pa., April 9, 2018 – AGC Chemicals Americas Inc. will feature advanced intermediates—fluorinated molecules that serve as building blocks for pharmaceutical products—at the CPhI North America Exhibition at booth 200. AGC also will showcase its lines of fine micro-spherical silica gels for use in cosmetics, personal care, catalyst supports and specialty applications.
AGC’s extensive experience working with fluorine, chlorine and iodine chemistries enable it to produce many hard-to-synthesize molecules in commercial scale. AGC also provides Contract Development and Manufacturing Organization (CDMO) services for pharmaceutical and biopharmaceutical developers under Current Good Manufacturing Practice (cGMP) conditions.
Features of AGC’s intermediates and ingredients for pharmaceuticals include:
Click here for more information about AGC intermediates.
Uniting niche and top buyers and sellers together under one roof in nine event locations around the world, CPhI hosts quality conferences, free seminars, awards and pharma community charity expeditions. The CPhI community is comprised of all job functions throughout the pharma supply chain. The Cphl North America 2018 event will be held April 24-26 at the Pennsylvania Convention Center, Philadelphia, PA. For more information, visit cphinorthamerica.com.
AGC Chemicals Americas, Inc. is a wholly owned subsidiary of AGC, Inc., a $13 billion multinational corporation and one of the world’s largest manufacturers of glass, electronic displays and chemical products. The company was formed in 2004 through the merging of sister companies Asahi Glass Fluoropolymers USA and AGA Chemicals. Headquartered in Exton, Pa., AGC Chemicals Americas maintains manufacturing operations in nearby Thorndale, Pa., and warehouses located throughout North America.